Brief: Essex Bio-Technology says co is exploring for a KDR programme on Korea Exchange
March 8 (Reuters) - Essex Bio-Technology Ltd 1061.HK
* Board announces that company is exploring for a KDR
programme on Korea Exchange
* As at date of this announcement, no application relating
to KDR programme has been made to Korea Exchange
Source text for Eikon: ID:nHKS7CHv4C
Further company coverage: 1061.HK
(Reporting by Hanna Paul)
((Hanna.Paul@thomsonreuters.com;))
Recent news on Essex Bio-Technology
See all newsHong Kong's Essex Bio-Technology H1 revenue falls
Brief: Essex Bio-Technology Posts HY Profit Of HK$110.7 MLN
Brief: Essex Bio-Technology Expects 10% Revenue And 30% Profit Decrease For HY
Brief: Shanghai Henlius Biotech Says Phase 3 Study Of HLX04-O For WAMD Meets Primary Endpoint
Brief: Essex Bio-Technology Posts Final Dividend Of HK$0.07 Per Share